THL – TorHoerman Law

BenicarHigh Blood Pressure Drug Linked to Intestinal Problems

Benicar Lawsuit – Blood Pressure Medicine Linked to Adverse Health Risks

The FDA warns that the high blood pressure drug, Benicar (olmesartan medoxomil) can cause intestinal problems known as sprue-like enteropathy. Gastrointestinal symptoms associated with sprue-like enteropathy include severe, chronic diarrhea and substantial weight loss. A Benicar lawsuit has been filed on behalf of individuals who have suffered injuries relating to these claims.

At this time, TorHoerman Law is no longer taking Benicar Lawsuit cases.

Litigation Updates

$300 Settlement Reached in July 2017 – Courts Working On Resolution

April 2018 -- In August of 2017, a global settlement of $300 million was announced with Defendants Daiichi Sankyo and Forest Laboratories. Since then, the Court and the parties have been working together to effectively put in motion a resolution process that efficiently handles the complexities of the case.

In August of 2017, a global settlement of $300 million was announced with Defendants Daiichi Sankyo and Forest Laboratories. Since then, the Court and the parties have been working together to effectively put in motion a resolution process that efficiently handles the complexities of the case. The Court has already required two preliminary census submissions so as to get a general idea of the number of plaintiffs who may qualify for the settlement. The deadline for plaintiffs to opt-in to the settlement is in May 2018. This deadline will be followed by a review and appeal process which will lead us into individual allocations. We are optimistic that by early 2019 our clients will have an idea of their case’s potential settlement value.

Diacetyl: Our office is currently litigating these cases across the country with lawsuits filed in California, Missouri, Illinois, and Ohio. We anticipate that by the end of 2018, this number will only grow as we meet more individuals who have been injured by this dangerous product. While these cases are all at varying stages, we anticipate at least some to be in trial by the end of 2018.

 

Visit: https://www.torhoermanlaw.com/300-million-benicar-settlement-reached/ for more information on July's settlement.

Read More Read Less

What is Benicar?

Benicar is an angiotensin receptor blocker (ARB) used to treat high blood pressure (hypertension). It is sometimes given together with other blood pressure medications. Benicar is one of eight marketed ARB drugs, and the only one linked to sprue-like enteropathy.

Benicar was first approved for market in 2002. It is manufactured by Daiichi Sankyo.

Benicar lawyers at TorHoerman Law are currently speaking to individuals prescribed Benicar who experienced serious gastrointestinal side effects and may want to consider participation in the Benicar side effect lawsuit.

The symptoms of Benicar enteropathy look very similar to those of Celiac Disease. But, unlike Celiac Disease, a gluten-free lifestyle will not improve the symptoms. The only way to improve Benicar enteropathy is by discontinuing the medication. If you have experienced any of the following side effects and you have been prescribed Benicar for hypertension, contact your health care professional right away.

Benicar Lawsuit

On July 4, 2013, the FDA issued a warning that Benicar causes sprue-like enteropathy. According to the FDA warning, symptoms of sprue-like enteropathy include severe, chronic diarrhea with substantial weight loss. The FDA approved changes to the labels of Benicar to include this concern.

The FDA previously sent Benicar manufacturer, Daiichi Sankyo, a warning regarding the manufacturer’s false advertising of Benicar. In 2010, the FDA released a warning that Benicar may increase the risk of death in diabetic patients.

Prior to the FDA warning, in 2012 the Mayo Clinic in Rochester, Minnesota studied 22 patients hospitalized and presenting symptoms similar to celiac disease – unexplained chronic diarrhea, weight loss and enteropathy. But, unlike celiac disease, these patients were unable to control these symptoms with a gluten-free lifestyle and antibody blood tests did not support a diagnosis of celiac disease.

The Mayo Clinic discovered that each of the patients was prescribed Benicar for their hypertension. Suspecting this was more than a coincidence, the Mayo clinic asked the severely injured patients to discontinue their use of Benicar. After discontinuing Benicar, the patients confirmed that chronic diarrhea, vomiting, weight loss and other intestinal inflammation symptoms improved. Furthermore, after discontinuing Benicar, the patients gained an average of 27 pounds.

Following this link, an additional 40 patients have been determined to have Benicar-associated sprue-like enteropathy. These numbers are likely to increase given the significant delay between the onset of severe sprue-like enteropathy and the start of the medication.

Multiple studies released in 2014 support a link between Benicar and sprue-like enteropathy,

Lawyers have joined the Benicar Enteropathy Lawsuit with individuals that suffered serious injuries and damages as a result of their Benicar usage. TorHoerman Law will not charge you for an initial consultation to discuss your side effects. You are not under any obligation to move forward with a Benicar lawsuit until you determine this is the right option for yourself and your family. All information provided to TorHoerman Law will be used to determine your legal rights to participate in the Benicar Side Effect Lawsuit and will be kept confidential.

 

+ - References

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021286s036lbl.pdf

No-Obligation Free Consultation

Contact us by phone at (618) 656-4400 or email us below.

Sidebar Contact

Your information will be used only so that we may contact you to evaluate your case. Your contact information will never be shared or sold to anyone other than TorHoerman Law.